 | • レポートコード：MRC2-11QY12200 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はHIV診断・治療のグローバル市場について調査・分析したレポートです。種類別（ELISA検査、唾液検査、ウイルス量検査、ウエスタンブロット、その他）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別HIV診断・治療の競争状況、市場シェア ・世界のHIV診断・治療市場：種類別市場規模 2015年-2020年（ELISA検査、唾液検査、ウイルス量検査、ウエスタンブロット、その他） ・世界のHIV診断・治療市場：種類別市場規模予測 2021年-2026年（ELISA検査、唾液検査、ウイルス量検査、ウエスタンブロット、その他） ・世界のHIV診断・治療市場：用途別市場規模 2015年-2020年（病院、クリニック） ・世界のHIV診断・治療市場：用途別市場規模予測 2021年-2026年（病院、クリニック） ・北米のHIV診断・治療市場分析：米国、カナダ ・ヨーロッパのHIV診断・治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのHIV診断・治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のHIV診断・治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのHIV診断・治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Laboratories、Boehringer Ingelheim、Bristol-Myers Squibb、Cipla、F. Hoffmann-La Roche、Gilead、GlaxoSmithKline、Johnson & Johnson ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
HIV prevalence in Africa, specifically in Southern region is very high as compared to North African region. Approximately 1 out of 4 is suffering from HIV. Southern and Eastern region of Africa has one of the highest prevalence rate of HIV, about 19 million people have HIV. While HIV prevalence is low in North Africa but the number of cases of HIV are increasing rapidly. There is no cure for HIV but drugs manufacturing companies are investing huge money in R&D to develop drugs for HIV.
Over 3000 patients were died in sub Saharan Africa due to HIV in 2015. Following 10 countries from Africa consists of 80% of total HIV burden which are South Africa, Kenya, Malawi, Ethiopia, Mozambique, United Republic of Tanzania, Nigeria, Uganda, Zimbabwe and Zambia.
Market Analysis and Insights: Global HIV Diagnosis & Treatment Market
The global HIV Diagnosis & Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global HIV Diagnosis & Treatment Scope and Market Size
HIV Diagnosis & Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global HIV Diagnosis & Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Laboratories
Boehringer Ingelheim
Bristol-Myers Squibb
Cipla
F. Hoffmann-La Roche
Gilead
GlaxoSmithKline
Johnson & Johnson
Market segment by Type, the product can be split into
ELISA Test
Saliva Tests
Viral Load Test
Western Blot
Others
Market segment by Application, split into
Hospitals
Clinics
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by HIV Diagnosis & Treatment Revenue
1.4 Market by Type
1.4.1 Global HIV Diagnosis & Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 ELISA Test
1.4.3 Saliva Tests
1.4.4 Viral Load Test
1.4.5 Western Blot
1.4.6 Others
1.5 Market by Application
1.5.1 Global HIV Diagnosis & Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global HIV Diagnosis & Treatment Market Perspective (2015-2026)
2.2 Global HIV Diagnosis & Treatment Growth Trends by Regions
2.2.1 HIV Diagnosis & Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 HIV Diagnosis & Treatment Historic Market Share by Regions (2015-2020)
2.2.3 HIV Diagnosis & Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 HIV Diagnosis & Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key HIV Diagnosis & Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top HIV Diagnosis & Treatment Players by Market Size
3.1.1 Global Top HIV Diagnosis & Treatment Players by Revenue (2015-2020)
3.1.2 Global HIV Diagnosis & Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global HIV Diagnosis & Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global HIV Diagnosis & Treatment Market Concentration Ratio
3.2.1 Global HIV Diagnosis & Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by HIV Diagnosis & Treatment Revenue in 2019
3.3 HIV Diagnosis & Treatment Key Players Head office and Area Served
3.4 Key Players HIV Diagnosis & Treatment Product Solution and Service
3.5 Date of Enter into HIV Diagnosis & Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global HIV Diagnosis & Treatment Historic Market Size by Type (2015-2020)
4.2 Global HIV Diagnosis & Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global HIV Diagnosis & Treatment Market Size by Application (2015-2020)
5.2 Global HIV Diagnosis & Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America HIV Diagnosis & Treatment Market Size (2015-2020)
6.2 HIV Diagnosis & Treatment Key Players in North America (2019-2020)
6.3 North America HIV Diagnosis & Treatment Market Size by Type (2015-2020)
6.4 North America HIV Diagnosis & Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe HIV Diagnosis & Treatment Market Size (2015-2020)
7.2 HIV Diagnosis & Treatment Key Players in Europe (2019-2020)
7.3 Europe HIV Diagnosis & Treatment Market Size by Type (2015-2020)
7.4 Europe HIV Diagnosis & Treatment Market Size by Application (2015-2020)
8 China
8.1 China HIV Diagnosis & Treatment Market Size (2015-2020)
8.2 HIV Diagnosis & Treatment Key Players in China (2019-2020)
8.3 China HIV Diagnosis & Treatment Market Size by Type (2015-2020)
8.4 China HIV Diagnosis & Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan HIV Diagnosis & Treatment Market Size (2015-2020)
9.2 HIV Diagnosis & Treatment Key Players in Japan (2019-2020)
9.3 Japan HIV Diagnosis & Treatment Market Size by Type (2015-2020)
9.4 Japan HIV Diagnosis & Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia HIV Diagnosis & Treatment Market Size (2015-2020)
10.2 HIV Diagnosis & Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia HIV Diagnosis & Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia HIV Diagnosis & Treatment Market Size by Application (2015-2020)
11 India
11.1 India HIV Diagnosis & Treatment Market Size (2015-2020)
11.2 HIV Diagnosis & Treatment Key Players in India (2019-2020)
11.3 India HIV Diagnosis & Treatment Market Size by Type (2015-2020)
11.4 India HIV Diagnosis & Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America HIV Diagnosis & Treatment Market Size (2015-2020)
12.2 HIV Diagnosis & Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America HIV Diagnosis & Treatment Market Size by Type (2015-2020)
12.4 Central & South America HIV Diagnosis & Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview
13.1.3 Abbott Laboratories HIV Diagnosis & Treatment Introduction
13.1.4 Abbott Laboratories Revenue in HIV Diagnosis & Treatment Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Boehringer Ingelheim
13.2.1 Boehringer Ingelheim Company Details
13.2.2 Boehringer Ingelheim Business Overview
13.2.3 Boehringer Ingelheim HIV Diagnosis & Treatment Introduction
13.2.4 Boehringer Ingelheim Revenue in HIV Diagnosis & Treatment Business (2015-2020)
13.2.5 Boehringer Ingelheim Recent Development
13.3 Bristol-Myers Squibb
13.3.1 Bristol-Myers Squibb Company Details
13.3.2 Bristol-Myers Squibb Business Overview
13.3.3 Bristol-Myers Squibb HIV Diagnosis & Treatment Introduction
13.3.4 Bristol-Myers Squibb Revenue in HIV Diagnosis & Treatment Business (2015-2020)
13.3.5 Bristol-Myers Squibb Recent Development
13.4 Cipla
13.4.1 Cipla Company Details
13.4.2 Cipla Business Overview
13.4.3 Cipla HIV Diagnosis & Treatment Introduction
13.4.4 Cipla Revenue in HIV Diagnosis & Treatment Business (2015-2020)
13.4.5 Cipla Recent Development
13.5 F. Hoffmann-La Roche
13.5.1 F. Hoffmann-La Roche Company Details
13.5.2 F. Hoffmann-La Roche Business Overview
13.5.3 F. Hoffmann-La Roche HIV Diagnosis & Treatment Introduction
13.5.4 F. Hoffmann-La Roche Revenue in HIV Diagnosis & Treatment Business (2015-2020)
13.5.5 F. Hoffmann-La Roche Recent Development
13.6 Gilead
13.6.1 Gilead Company Details
13.6.2 Gilead Business Overview
13.6.3 Gilead HIV Diagnosis & Treatment Introduction
13.6.4 Gilead Revenue in HIV Diagnosis & Treatment Business (2015-2020)
13.6.5 Gilead Recent Development
13.7 GlaxoSmithKline
13.7.1 GlaxoSmithKline Company Details
13.7.2 GlaxoSmithKline Business Overview
13.7.3 GlaxoSmithKline HIV Diagnosis & Treatment Introduction
13.7.4 GlaxoSmithKline Revenue in HIV Diagnosis & Treatment Business (2015-2020)
13.7.5 GlaxoSmithKline Recent Development
13.8 Johnson & Johnson
13.8.1 Johnson & Johnson Company Details
13.8.2 Johnson & Johnson Business Overview
13.8.3 Johnson & Johnson HIV Diagnosis & Treatment Introduction
13.8.4 Johnson & Johnson Revenue in HIV Diagnosis & Treatment Business (2015-2020)
13.8.5 Johnson & Johnson Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. HIV Diagnosis & Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by HIV Diagnosis & Treatment Revenue
Table 3. Ranking of Global Top HIV Diagnosis & Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global HIV Diagnosis & Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of ELISA Test
Table 6. Key Players of Saliva Tests
Table 7. Key Players of Viral Load Test
Table 8. Key Players of Western Blot
Table 9. Key Players of Others
Table 10. Global HIV Diagnosis & Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global HIV Diagnosis & Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global HIV Diagnosis & Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global HIV Diagnosis & Treatment Market Share by Regions (2015-2020)
Table 14. Global HIV Diagnosis & Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global HIV Diagnosis & Treatment Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. HIV Diagnosis & Treatment Market Growth Strategy
Table 20. Main Points Interviewed from Key HIV Diagnosis & Treatment Players
Table 21. Global HIV Diagnosis & Treatment Revenue by Players (2015-2020) (Million US$)
Table 22. Global HIV Diagnosis & Treatment Market Share by Players (2015-2020)
Table 23. Global Top HIV Diagnosis & Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV Diagnosis & Treatment as of 2019)
Table 24. Global HIV Diagnosis & Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players HIV Diagnosis & Treatment Product Solution and Service
Table 27. Date of Enter into HIV Diagnosis & Treatment Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global HIV Diagnosis & Treatment Market Size by Type (2015-2020) (Million US$)
Table 30. Global HIV Diagnosis & Treatment Market Size Share by Type (2015-2020)
Table 31. Global HIV Diagnosis & Treatment Revenue Market Share by Type (2021-2026)
Table 32. Global HIV Diagnosis & Treatment Market Size Share by Application (2015-2020)
Table 33. Global HIV Diagnosis & Treatment Market Size by Application (2015-2020) (Million US$)
Table 34. Global HIV Diagnosis & Treatment Market Size Share by Application (2021-2026)
Table 35. North America Key Players HIV Diagnosis & Treatment Revenue (2019-2020) (Million US$)
Table 36. North America Key Players HIV Diagnosis & Treatment Market Share (2019-2020)
Table 37. North America HIV Diagnosis & Treatment Market Size by Type (2015-2020) (Million US$)
Table 38. North America HIV Diagnosis & Treatment Market Share by Type (2015-2020)
Table 39. North America HIV Diagnosis & Treatment Market Size by Application (2015-2020) (Million US$)
Table 40. North America HIV Diagnosis & Treatment Market Share by Application (2015-2020)
Table 41. Europe Key Players HIV Diagnosis & Treatment Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players HIV Diagnosis & Treatment Market Share (2019-2020)
Table 43. Europe HIV Diagnosis & Treatment Market Size by Type (2015-2020) (Million US$)
Table 44. Europe HIV Diagnosis & Treatment Market Share by Type (2015-2020)
Table 45. Europe HIV Diagnosis & Treatment Market Size by Application (2015-2020) (Million US$)
Table 46. Europe HIV Diagnosis & Treatment Market Share by Application (2015-2020)
Table 47. China Key Players HIV Diagnosis & Treatment Revenue (2019-2020) (Million US$)
Table 48. China Key Players HIV Diagnosis & Treatment Market Share (2019-2020)
Table 49. China HIV Diagnosis & Treatment Market Size by Type (2015-2020) (Million US$)
Table 50. China HIV Diagnosis & Treatment Market Share by Type (2015-2020)
Table 51. China HIV Diagnosis & Treatment Market Size by Application (2015-2020) (Million US$)
Table 52. China HIV Diagnosis & Treatment Market Share by Application (2015-2020)
Table 53. Japan Key Players HIV Diagnosis & Treatment Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players HIV Diagnosis & Treatment Market Share (2019-2020)
Table 55. Japan HIV Diagnosis & Treatment Market Size by Type (2015-2020) (Million US$)
Table 56. Japan HIV Diagnosis & Treatment Market Share by Type (2015-2020)
Table 57. Japan HIV Diagnosis & Treatment Market Size by Application (2015-2020) (Million US$)
Table 58. Japan HIV Diagnosis & Treatment Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players HIV Diagnosis & Treatment Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players HIV Diagnosis & Treatment Market Share (2019-2020)
Table 61. Southeast Asia HIV Diagnosis & Treatment Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia HIV Diagnosis & Treatment Market Share by Type (2015-2020)
Table 63. Southeast Asia HIV Diagnosis & Treatment Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia HIV Diagnosis & Treatment Market Share by Application (2015-2020)
Table 65. India Key Players HIV Diagnosis & Treatment Revenue (2019-2020) (Million US$)
Table 66. India Key Players HIV Diagnosis & Treatment Market Share (2019-2020)
Table 67. India HIV Diagnosis & Treatment Market Size by Type (2015-2020) (Million US$)
Table 68. India HIV Diagnosis & Treatment Market Share by Type (2015-2020)
Table 69. India HIV Diagnosis & Treatment Market Size by Application (2015-2020) (Million US$)
Table 70. India HIV Diagnosis & Treatment Market Share by Application (2015-2020)
Table 71. Central & South America Key Players HIV Diagnosis & Treatment Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players HIV Diagnosis & Treatment Market Share (2019-2020)
Table 73. Central & South America HIV Diagnosis & Treatment Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America HIV Diagnosis & Treatment Market Share by Type (2015-2020)
Table 75. Central & South America HIV Diagnosis & Treatment Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America HIV Diagnosis & Treatment Market Share by Application (2015-2020)
Table 77. Abbott Laboratories Company Details
Table 78. Abbott Laboratories Business Overview
Table 79. Abbott Laboratories Product
Table 80. Abbott Laboratories Revenue in HIV Diagnosis & Treatment Business (2015-2020) (Million US$)
Table 81. Abbott Laboratories Recent Development
Table 82. Boehringer Ingelheim Company Details
Table 83. Boehringer Ingelheim Business Overview
Table 84. Boehringer Ingelheim Product
Table 85. Boehringer Ingelheim Revenue in HIV Diagnosis & Treatment Business (2015-2020) (Million US$)
Table 86. Boehringer Ingelheim Recent Development
Table 87. Bristol-Myers Squibb Company Details
Table 88. Bristol-Myers Squibb Business Overview
Table 89. Bristol-Myers Squibb Product
Table 90. Bristol-Myers Squibb Revenue in HIV Diagnosis & Treatment Business (2015-2020) (Million US$)
Table 91. Bristol-Myers Squibb Recent Development
Table 92. Cipla Company Details
Table 93. Cipla Business Overview
Table 94. Cipla Product
Table 95. Cipla Revenue in HIV Diagnosis & Treatment Business (2015-2020) (Million US$)
Table 96. Cipla Recent Development
Table 97. F. Hoffmann-La Roche Company Details
Table 98. F. Hoffmann-La Roche Business Overview
Table 99. F. Hoffmann-La Roche Product
Table 100. F. Hoffmann-La Roche Revenue in HIV Diagnosis & Treatment Business (2015-2020) (Million US$)
Table 101. F. Hoffmann-La Roche Recent Development
Table 102. Gilead Company Details
Table 103. Gilead Business Overview
Table 104. Gilead Product
Table 105. Gilead Revenue in HIV Diagnosis & Treatment Business (2015-2020) (Million US$)
Table 106. Gilead Recent Development
Table 107. GlaxoSmithKline Company Details
Table 108. GlaxoSmithKline Business Overview
Table 109. GlaxoSmithKline Product
Table 110. GlaxoSmithKline Revenue in HIV Diagnosis & Treatment Business (2015-2020) (Million US$)
Table 111. GlaxoSmithKline Recent Development
Table 112. Johnson & Johnson Business Overview
Table 113. Johnson & Johnson Product
Table 114. Johnson & Johnson Company Details
Table 115. Johnson & Johnson Revenue in HIV Diagnosis & Treatment Business (2015-2020) (Million US$)
Table 116. Johnson & Johnson Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global HIV Diagnosis & Treatment Market Share by Type: 2020 VS 2026
Figure 2. ELISA Test Features
Figure 3. Saliva Tests Features
Figure 4. Viral Load Test Features
Figure 5. Western Blot Features
Figure 6. Others Features
Figure 7. Global HIV Diagnosis & Treatment Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. HIV Diagnosis & Treatment Report Years Considered
Figure 11. Global HIV Diagnosis & Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global HIV Diagnosis & Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global HIV Diagnosis & Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global HIV Diagnosis & Treatment Market Share by Players in 2019
Figure 16. Global Top HIV Diagnosis & Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV Diagnosis & Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by HIV Diagnosis & Treatment Revenue in 2019
Figure 18. North America HIV Diagnosis & Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe HIV Diagnosis & Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China HIV Diagnosis & Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan HIV Diagnosis & Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia HIV Diagnosis & Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India HIV Diagnosis & Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America HIV Diagnosis & Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
ミトコンドリアミオパチー診断・治療の世界市場（～2026年） Mitochondrial myopathies are types of myopathies associated with mitochondrial disease. On biopsy, the muscle tissue of patients with these diseases usually demonstrate "ragged red" muscle fibers. These ragged-red fibers contain mild accumulations of glycogen and neutral lipids, and may show an incr…- 癲癇診断・治療の世界市場（～2026年） Epilepsy is a neurological disorder affecting the central nervous system. In this medical condition, the brain exhibits abnormal activity, which results in periods of unusual behavior or seizures and sometimes, loss of awareness. Temporary confusion, anxiety, uncontrollable jerking movements of the …
- 結核診断・治療の世界市場（～2026年） An infectious disease caused by the bacterium Mycobacterium tuberculosis (MTB) is known as Tuberculosis (TB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. The rising screening rate in the high burden regions, faster clinical decisions, and affordability of d…
- クラミジア診断・治療の世界市場（～2026年） Chlamydia trachomatis is a type of sexually transmitted disease that is prevalent in population of all age group, but women are much more vulnerable to it. The Chlamydia diagnosis involves a series of test such as urine culture, The change in lifestyle especially related to sex preferences is the ma…
- 髄膜炎診断・治療の世界市場（～2026年） Meningitis is an acute inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges. The most common symptoms are fever, headache, and neck stiffness. Other symptoms include confusion or altered consciousness, vomiting, and an inability to tolerate …